Omnicell
$121.629876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$121.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.95 (+0.79%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Omnicell and other stocks, options, and ETFs commission-free!
About OMCL
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA. The listed name for OMCL is Omnicell, Inc. Common Stock ($0.001 par value).
CEO
Randall A. Lipps
Employees
2,700
Headquarters
Mountain View, California
Founded
1992
Market Cap
5.02B
Price-Earnings Ratio
138.70
Dividend Yield
—
Average Volume
497.73K
High Today
$122.99
Low Today
$120.13
Open Price
$121.50
Volume
310.47K
52 Week High
$125.00
52 Week Low
$54.24
Collections
Analyst Ratings
56%
of 9 ratings
Buy
56%
Hold
44%
Sell
0%
OMCL Earnings
$0.00
$0.26
$0.52
$0.78
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Feb 1, After Hours